The Alcidion share price gained as much as 16% today after it released its quarterly results to June 2021.

Australian Clinical Labs (ASX:ACL) will benefit from high levels of covid testing in Australia.

Damstra shares are trading 13% higher after the company reported record revenue in the fourth quarter of FY 2021.

IntelliHR (ASX: IHR) share price have been a rollercoaster over the last year, but the IntelliHR quarterly results show good organic growth.

Finbar (ASX:FRI) raised its dividend but not by as much as I had hoped for.

Including an important clarification regarding the way Rightcrowd reports ARR.

Eroad has more success in New Zealand than the USA, but acquiring Coretex may well be the best move to drive international growth faster.

8Common (ASX:8CO) keeps promising growth but the receipts from customers are down.

Austco Healthcare (ASX:AHC) has profits, a global client base, and potential for post-pandemic growth. But its chequered past haunts the stock.

Objective Corporation (ASX:OCL) has reported record revenue, record profit, and record annualised recurring revenue, in FY 2021. But is its valuation too punchy?

The Xref (ASX:XF1) share price has gained over 16% on a record result which sees the company achieve free cash flow breakeven in FY2021.

Dicker Data is forecasting a record profit which allays my concerns about its transition to a bigger warehouse.

One director of this boring dividend payer just bought a fair chunk of shares at slightly above the current price.

The Redbubble (ASX: RBL) share price gained over 500% during the pandemic, but the business model is badly misunderstood.

Damstra’s share price is back where it was a year ago. What went wrong, and is this an opportunity or the time to give up?

IntelliHR (ASX: IHR) looks to have reached an inflection point with its revenue growth, but it’s a long way from profitability. Here’s why it’s worth watching.

Medical Developments International (ASX:MVP) shares look attractive at current prices given the potential for significant Penthrox sales growth.

I’m finding these 5 (3 old, 2 new) micro-caps tempting at current prices…

Macquarie notes that Sezzle’s Appstore ranking has improved, but their analysis barely scratches the surface. Are Sezzle (ASX:SZL) shareholders in the dark?

These three stocks have seen insider buying and have decent prospects in the next few years.